• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchDesign Therapeutics
    Picture of Design Therapeutics logo

    DSGN — Design Therapeutics Share News

    $10.490.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    • Market Cap
      $656.48m
    • Enterprise Value
      $449.09m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • DSGN Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    DSGN Dividends
    • Brief: Design Therapeutics Posts Quarterly Loss Per Share Of $0.14

      09/08/2021 21:48
    • Brief: Design Therapeutics Expands Board Of Directors With Key Appointments

      07/06/2021 21:24
    • Brief: Design Therapeutics Posts Quarterly Loss Per Share Of 31 Cents

      10/05/2021 22:28
    • Design Therapeutics: Surges 40% in stock market debut

      26/03/2021 18:49
    • NASDAQ RESUMED AT 12:43 PM

      26/03/2021 16:43
    • NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

      26/03/2021 08:01
    • Brief: Design Therapeutics Announces Pricing Of Initial Public Offering

      26/03/2021 05:32
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.